Summary

The Director, Medical Managed Care (DMMC) is a critical field-based liaison position which involves the development and execution of specific payer communication plans for delivering scientific, clinical and health economic information for Duchenne muscular dystrophy (DMD) and Sarepta marketed and pipeline products. During execution of these communication plans, the Director, Medical Managed Care is tasked with ensuring the delivery of scientifically credible and consistent key value messages to public and private payer segments. This role serves as a scientific resource for a number of key customers including, but not limited to, clinical decision makers in the payer and managed care community. Additionally, this role actively contributes to the development of medical resources to support payer education regarding DMD and the safe and appropriate use of Sarepta products.

Job description

The Importance of the Role

The Director, Medical Managed Care (DMMC) is a critical field-based liaison position which involves the development and execution of specific payer communication plans for delivering scientific, clinical and health economic information for Duchenne muscular dystrophy (DMD) and Sarepta marketed and pipeline products. During execution of these communication plans, the Director, Medical Managed Care is tasked with ensuring the delivery of scientifically credible and consistent key value messages to public and private payer segments. This role serves as a scientific resource for a number of key customers including, but not limited to, clinical decision makers in the payer and managed care community. Additionally, this role actively contributes to the development of medical resources to support payer education regarding DMD and the safe and appropriate use of Sarepta products.

The Opportunity to Make a Difference

Identify, develop and maintain relationships with key clinical decision makers within the payer and managed care community
Develop and maintain credible and independent relationships with key medical, pharmacy, quality & health economics/outcomes/analytics opinion leaders within assigned accounts
Work closely with Director National Accounts to help educate payer and market access customers on disease and treatment
Interface with key customers/opinion leaders and assist internal stakeholders in interpretation of key scientific data to support policy decision-makers
Prepare and deliver fair-balanced and comprehensive responses to clinical and scientific concerns of payer/managed care customers
Communicate scientific information clearly in a variety of settings, including internal meetings, advisory boards, and 1:1 or group discussions with clinical decision makers, as requested
Provide assistance in the development of payer tools/dossiers to demonstrate value from a payer perspective to support the safe and appropriate use of Sarepta products
Participate in internal training and planning of national and regional opinion leader meetings
Attend select scientific meetings and professional conferences for the purpose of providing Medical Affairs support and engaging in scientific exchange with key decision makers
Provide GMA leadership with customer insights and correlating business recommendations
Other related duties as required

More about You

BA/BS required. MD, PhD, or PharmD strongly preferred; MBA or additional degree in health economics, health outcomes, public health or health policy is a plus
10+ years of related experience with 3-5 years of pharmaceutical industry, managed care experience, or similar organizational experience required (e.g., field based medical/HEOR, value-access, market access)
Strong Scientific and Pharmaceutical and Health Outcomes knowledge; preferably industry derived. Strong understanding of current US Healthcare system
Highly driven individual with the ability to combine scientific knowledge with a focus on customer service and compassion for the patients we serve
Familiarity with and track record of complying with industry and regulatory compliance guidelines
Demonstrated ability to work independently and in collaborative team environment
Excellent written and verbal communication skills, exceptional listening skills, strong presentation skills, and good negotiating and influencing skills
Willingness to travel >50%

Requirements

BA/BS required
MD, PhD, or PharmD strongly preferred
MBA or additional degree in health economics, health outcomes, public health or health policy is a plus
10+ years of related experience
3-5 years of pharmaceutical industry, managed care experience, or similar organizational experience required
Strong Scientific and Pharmaceutical and Health Outcomes knowledge
Strong understanding of current US Healthcare system
Familiarity with and track record of complying with industry and regulatory compliance guidelines
Demonstrated ability to work independently and in collaborative team environment
Excellent written and verbal communication skills
Exceptional listening skills
Strong presentation skills
Good negotiating and influencing skills
Willingness to travel >50%

Benefits

Physical and Emotional Wellness
Financial Wellness
Support for Caregivers

Company overview

Sarepta Therapeutics is a global biotechnology company headquartered in Cambridge, Massachusetts, focused on developing precision genetic medicines for rare diseases. Founded in 1980, the company has evolved into a commercial-stage biopharmaceutical leader with a specialized focus on RNA-based therapeutics and gene therapies. Sarepta's primary mission centers on treating devastating rare genetic disorders, particularly Duchenne muscular dystrophy (DMD), a progressive muscle-wasting disease affecting children. The company has developed multiple FDA-approved treatments including Exondys 51, Amondys 45, Vyondys 53, and the groundbreaking gene therapy ELEVIDYS. Sarepta employs approximately 1,300-1,400 professionals and maintains research facilities across multiple locations. The company's scientific platform leverages Morpholino oligomer technology for exon-skipping therapies and advanced adeno-associated virus (AAV) vectors for gene therapy delivery. With a market capitalization exceeding $2 billion, Sarepta continues to expand its pipeline to address additional rare diseases while building the world's largest gene therapy manufacturing capacity to accelerate patient access to transformative treatments.